These data indicate the importance of serum biomarkers reflecting the fibrotic process in patients with IgG4-RD and therefore we focused on the significance of GDF-15 and CCL2 in our present investigation. Here, CCL2 is linked to immunoglobulin G4-related sclerosing disease.